Daniel Swisher
Förmögenhet: 447 017 $ per 2026-05-31
Förmögenhet: 447 017 $ per 2026-05-31
Daniel N.
Swisher is an Independent Director at Corcept Therapeutics, Inc. since 2015.
Formerly, Mr. Swisher was President, CEO, Secretary & Director at Sunesis Pharmaceuticals, Inc. in 2017.
Served as Chief Executive Officer & Director at NodThera Ltd. from 2024 to 2026.
Held the position of Chairman at Cerus Corp.
from 2013 to 2025.
Worked as Director at Protagonist Therapeutics, Inc. from 2023 to 2024.
Was Senior Vice President-Sales & Marketing at ALZA Corp.
from 1992 to 2001.
Served as President at Jazz Pharmaceuticals Plc from 2021 to 2023.
Education includes undergraduate studies at Yale University and an MBA from Stanford Graduate School of Business, conferred in 1991.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CERUS CORPORATION 0,07 % | 2025-06-03 | 147 045 ( 0,07 % ) | 447 017 $ | 2026-05-31 |
| 2026-05-21 | 0 ( -.--% ) | - $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Direktör/Styrelseledamot | 2015-06-18 |
| Företag | Position | Slut |
|---|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Verkställande Direktör | 2026-02-04 |
| CERUS CORPORATION | Ordförande | 2025-06-16 |
| PROTAGONIST THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2024-09-17 |
| JAZZ PHARMACEUTICALS PLC | President | 2023-10-01 |
| VIRACTA THERAPEUTICS, INC. | Verkställande Direktör | 2017-12-31 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Corcept Therapeutics, Inc.
Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån